Teva jumps on biologics bandwagon with $400m buy
Israeli generics behemoth Teva is following the market and banking on the promise of biologics with its purchase of Human Genome Sciences biotech spin-off, CoGenesys.
Israeli generics behemoth Teva is following the market and banking on the promise of biologics with its purchase of Human Genome Sciences biotech spin-off, CoGenesys.
Eli Lilly has released a statement strongly objecting to implications made in a New York Times article that it has suppressed results of negative clinical trials.
The world's most powerful transmission electron microscope has been turned on in the US, with single-atom resolution bringing within reach the ability to analyse chemicals simply by looking at them.
Vapourtec has made two new additions to its Flow Chemistry platform available as the company make headway in an emerging field, which aims to speed up laboratory processes in drug discovery.